Vishpha

Executive Summary

Vishpha is a privately held Ukrainian pharmaceutical manufacturer founded in 1996, specializing in generic drugs with a strong emphasis on herbal and plant-based active ingredients. Operating under two brands—TM Vishpha and TM ZPF (Zhytomyr pharmaceutical factory)—the company has secured a position among the top 10 domestic producers in Ukraine. Its product portfolio focuses on medications derived from crude plant extracts, catering to the growing demand for natural-based therapeutics. While Vishpha's current operations are primarily domestic, the company benefits from Ukraine's cost-competitive manufacturing environment and a loyal customer base. However, geopolitical risks and regulatory challenges in export markets limit near-term growth visibility. The company remains privately held with no disclosed funding rounds or valuation, suggesting a conservative growth trajectory.

Upcoming Catalysts (preview)

• 2027EU Regulatory Certification60% success
• 2026New Herbal Drug Product Launch70% success
• 2026Strategic Distribution Partnership in Eastern Europe50% success